SPINOCEREBELLAR ATAXIA 27B (SCA27B)

Clinical trials for SPINOCEREBELLAR ATAXIA 27B (SCA27B) explained in plain language.

Never miss a new study

Get alerted when new SPINOCEREBELLAR ATAXIA 27B (SCA27B) trials appear

Sign up with your email to follow new studies for SPINOCEREBELLAR ATAXIA 27B (SCA27B), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Breakthrough hope for rare brain disease as major drug trial begins

Disease control Recruiting now

This study is testing whether a drug called fampridine can improve movement control and vision problems in people with a specific genetic brain condition called SCA27B. It will involve 70 adults who have this condition. For 3 months, half will receive the real drug and half a pla…

Matched conditions: SPINOCEREBELLAR ATAXIA 27B (SCA27B)

Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

SPINOCEREBELLAR ATAXIA 27B (SCA27B)

Get alerted when new SPINOCEREBELLAR ATAXIA 27B (SCA27B) trials appear

Breakthrough hope for rare brain disease as major drug trial begins